Repeat Associated Non-ATG Translation Initiation: One DNA, Two Transcripts, Seven Reading Frames, Potentially Nine Toxic Entities!

Diseases associated with unstable repetitive elements in the DNA, RNA, and amino acids have consistently revealed scientific surprises. Most diseases are caused by expansions of trinucleotide repeats, which ultimately lead to diseases like Huntington's disease, myotonic dystrophy, fragile X syndrome, and a series of spinocerebellar ataxias. These repeat mutations are dynamic, changing through generations and within an individual, and the repeats can be bi-directionally transcribed. Unsuspected modes of pathogenesis involve aberrant loss of protein expression; aberrant over-expression of non-mutant proteins; toxic-gain-of-protein function through expanded polyglutamine tracts that are encoded by expanded CAG tracts; and RNA-toxic-gain-of-function caused by transcripts harboring expanded CUG, CAG, or CGG tracts. A recent advance reveals that RNA transcripts with expanded CAG repeats can be translated in the complete absence of a starting ATG, and this Repeat Associated Non-ATG translation (RAN-translation) occurs across expanded CAG repeats in all reading frames (CAG, AGC, and GCA) to produce homopolymeric proteins of long polyglutamine, polyserine, and polyalanine tracts. Expanded CTG tracts expressing CUG transcripts also show RAN-translation occurring in all three frames (CUG, UGC, and GCU), to produce polyleucine, polycysteine, and polyalanine. These RAN-translation products can be toxic. Thus, one unstable (CAG)•(CTG) DNA can produce two expanded repeat transcripts and homopolymeric proteins with reading frames (the AUG-directed polyGln and six RAN-translation proteins), yielding a total of potentially nine toxic entities. The occurrence of RAN-translation in patient tissues expands our horizons of modes of disease pathogenesis. Moreover, since RAN-translation counters the canonical requirements of translation initiation, many new questions are now posed that must be addressed. This review covers RAN-translation and some of the pertinent questions.

[1]  C. E. Pearson,et al.  Repeat instability as the basis for human diseases and as a potential target for therapy , 2010, Nature Reviews Molecular Cell Biology.

[2]  N. Oleinick.  Initiation and elongation of protein synthesis in growing cells: differential inhibition by cycloheximide and emetine. , 1977, Archives of biochemistry and biophysics.

[3]  C. E. Pearson.  FSHD: A Repeat Contraction Disease Finally Ready to Expand (Our Understanding of Its Pathogenesis) , 2010, PLoS genetics.

[4]  B. Oostra,et al.  FMR1: a gene with three faces. , 2009, Biochimica et biophysica acta.

[5]  T. Ebner,et al.  Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8 , 2006, Nature Genetics.

[6]  G. Coetzee,et al.  The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. , 1995, Cancer research.

[7]  M. Hayden,et al.  A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. , 1994, Human molecular genetics.

[8]  H. Smeets,et al.  Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients. , 2010, Human molecular genetics.

[9]  G. Rouleau,et al.  Molecular mechanisms underlying polyalanine diseases , 2009, Neurobiology of Disease.

[10]  Radim Mazanec,et al.  Highly unstable sequence interruptions of the CTG repeat in the myotonic dystrophy gene , 2009, American journal of medical genetics. Part A.

[11]  Daniel G. Miller,et al.  A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy , 2010, Science.

[12]  B. Brais,et al.  CAG tract of MJD-1 may be prone to frameshifts causing polyalanine accumulation. , 2000, Human molecular genetics.

[13]  D. Chitayat,et al.  Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues. , 2011, Human molecular genetics.

[14]  J. Taylor,et al.  Repeat expansion disease: progress and puzzles in disease pathogenesis , 2010, Nature Reviews Genetics.

[15]  M. Swanson,et al.  Pathogenic RNAs in microsatellite expansion disease , 2009, Neuroscience Letters.

[16]  S. Warren,et al.  Translational suppression by trinucleotide repeat expansion at FMR1 , 1995, Science.

[17]  M. Kozak,et al.  Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs , 1989, Molecular and cellular biology.

[18]  A. Prats,et al.  Generation of protein isoform diversity by alternative initiation of translation at non‐AUG codons , 2003, Biology of the cell.

[19]  J. Whisstock,et al.  Functional insights from the distribution and role of homopeptide repeat-containing proteins. , 2005, Genome research.

[20]  K. Merienne,et al.  SCA8 CAG/CTG Expansions, a Tale of Two TOXICities: A Unique or Common Case? , 2009, PLoS genetics.

[21]  S Karlin,et al.  Trinucleotide repeats and long homopeptides in genes and proteins associated with nervous system disease and development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Mirkin,et al.  Expansion of the (CTG)(n) repeat in the 5'-UTR of a reporter gene impedes translation. , 2000, Nucleic acids research.

[23]  Daniel G. Miller,et al.  Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene , 2010, PLoS genetics.

[24]  D. Chitayat,et al.  Tissue- and age-specific DNA replication patterns at the CTG/CAG-expanded human myotonic dystrophy type 1 locus , 2010, Nature Structural &Molecular Biology.

[25]  T. Ebner,et al.  RNA Gain-of-Function in Spinocerebellar Ataxia Type 8 , 2009, PLoS genetics.

[26]  A. Hinnebusch,et al.  Regulation of Translation Initiation in Eukaryotes: Mechanisms and Biological Targets , 2009, Cell.

[27]  D. Rubinsztein,et al.  Polyalanine and polyserine frameshift products in Huntington’s disease , 2006, Journal of Medical Genetics.

[28]  Tilman Schneider-Poetsch,et al.  Inhibition of Eukaryotic Translation Elongation by Cycloheximide and Lactimidomycin , 2010, Nature chemical biology.

[29]  Brian B. Gibbens,et al.  Non-ATG–initiated translation directed by microsatellite expansions , 2010, Proceedings of the National Academy of Sciences.

[30]  M. Swanson,et al.  Partners in crime: bidirectional transcription in unstable microsatellite disease. , 2010, Human molecular genetics.

[31]  R. Reilmann,et al.  Decreased plasma alanine and isoleucine in Huntington's disease , 1995, Acta neurologica Scandinavica.

[32]  T. Bird,et al.  SCA8 CTG repeat: en masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance. , 2000, Human molecular genetics.

[33]  Abel Rodríguez,et al.  Early Onset Prion Disease from Octarepeat Expansion Correlates with Copper Binding Properties , 2009, PLoS pathogens.

[34]  E. Jan.  Divergent IRES elements in invertebrates. , 2006, Virus research.

[35]  K. Sobczak,et al.  CAG Repeats Containing CAA Interruptions Form Branched Hairpin Structures in Spinocerebellar Ataxia Type 2 Transcripts* , 2005, Journal of Biological Chemistry.

[36]  N. Bonini,et al.  RNA toxicity is a component of ataxin-3 degeneration in Drosophila , 2008, Nature.

[37]  P. Hagerman,et al.  Initiation of translation of the FMR1 mRNA Occurs predominantly through 5'-end-dependent ribosomal scanning. , 2011, Journal of molecular biology.